Huaren Pharmaceutical Co.,Ltd.’s Net Profit Rose 11.1% in First Half of 2023

Huaren Pharmaceutical Co.,Ltd. (华仁药业股份有限公司) (300110.SZ) reported a net profit of 84.4 million yuan in the first half of 2023, up 11.1% year-on-year.

Meanwhile, the company posted 829 million yuan in revenue, up 14.8% year-on-year.

At the end of the reporting period, it had 5.3 billion yuan in total assets and 2.7 billion yuan in total liabilities, with a liability-to-asset ratio of 50%.